Literature DB >> 25676608

Development of a conjunctival tissue substitute on the basis of plastic compressed collagen.

C C Drechsler1, A Kunze1, A Kureshi2, G Grobe3, S Reichl3, G Geerling1, J T Daniels2, S Schrader1.   

Abstract

Ocular surface disorders, such as pterygium, cicatricial pemphigoid and external disruptions, can cause severe inflammation, scarring, fornix shortening as well as ankyloblepharon. Current treatments do not resolve these conditions sufficiently. The aim of this study was to evaluate clinical applicability and suitability of plastic compressed collagen to serve as a substrate for the expansion of human conjunctival epithelial cells in order to develop an epithelialized conjunctival substitute for fornix reconstruction. Human conjunctival epithelial cells were expanded on plastic compressed collagen gels. Epithelial cell characteristics were evaluated by haematoxylin and eosin staining, electron microscopy and cytokeratin expression. The expression of putative epithelial progenitor cell markers p63α, ABCG2 and CK15 was assessed by immunostaining. The proliferative capacity and clonal growth of the cells was evaluated before (P0) and after expansion (P1) on the plastic compressed collagen gels by colony forming efficiency assay. The potential clinical applicability of this gel substitutes was evaluated by assessment of their biomechanical properties as well as their surgical handling. Human conjunctival epithelial cells cultured on plastic and plastic compressed collagen gels formed a confluent cell layer and expressed CK19. The cells showed expression of the putative epithelial progenitor cell markers p63α, ABCG2 and CK15 and sustained colony forming ability. The compressed collagen gels showed a high ultimate tensile strength and elasticity and the surgical handling of gels was comparable to amniotic membrane. An epithelialized conjunctival tissue construct on the basis of compressed collagen might therefore be a promising alternative bioartificial tissue substitute for conjunctival reconstruction.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  conjunctiva; epithelial cell culture; ocular surface reconstruction; ophthalmology; plastic compressed collagen matrix; tissue engineering

Mesh:

Substances:

Year:  2015        PMID: 25676608     DOI: 10.1002/term.1991

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  6 in total

Review 1.  [New approaches to ocular surface reconstruction beyond the cornea].

Authors:  K Spaniol; C Holtmann; G Geerling; S Schrader
Journal:  Ophthalmologe       Date:  2017-04       Impact factor: 1.059

2.  Establishment of a bi-layered tissue engineered conjunctiva using a 3D-printed melt electrowritten poly-(ε-caprolactone) scaffold.

Authors:  Jiajun Xie; Qi Gao; Zelmira Nuñez Del Prado; Nandini Venkateswaran; Hazem M Mousa; Enrique Salero; Juan Ye; Elena M De Juan-Pardo; Alfonso L Sabater; Victor L Perez
Journal:  Int Ophthalmol       Date:  2022-08-06       Impact factor: 2.029

3.  Rapid bioprinting of conjunctival stem cell micro-constructs for subconjunctival ocular injection.

Authors:  Zheng Zhong; Xiaoqian Deng; Pengrui Wang; Claire Yu; Wisarut Kiratitanaporn; Xiaokang Wu; Jacob Schimelman; Min Tang; Alis Balayan; Emmie Yao; Jing Tian; Luwen Chen; Kang Zhang; Shaochen Chen
Journal:  Biomaterials       Date:  2020-10-23       Impact factor: 12.479

Review 4.  Concise Review: Comparison of Culture Membranes Used for Tissue Engineered Conjunctival Epithelial Equivalents.

Authors:  Jon Roger Eidet; Darlene A Dartt; Tor Paaske Utheim
Journal:  J Funct Biomater       Date:  2015-12-11

5.  An engineered human conjunctival-like tissue to study ocular surface inflammatory diseases.

Authors:  Laura García-Posadas; Laura Soriano-Romaní; Antonio López-García; Yolanda Diebold
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

6.  A Tenon's capsule/bulbar conjunctiva interface biomimetic to model fibrosis and local drug delivery.

Authors:  Katarzyna Kozdon; Bruna Caridi; Iheukwumere Duru; Daniel G Ezra; James B Phillips; Maryse Bailly
Journal:  PLoS One       Date:  2020-11-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.